This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
type-i-interferon
Type I Interferon
IFN-α/β (type I IFNs) are antiviral cytokines; cGAS-STING or RIG-I/MDA5 → TBK1 → IRF3/7 → IFN-α/β → IFNAR1/2 → JAK1/TYK2 → STAT1/STAT2 → ISGs. Type I IFN signature drives SLE, SSc, dermatomyositis; anifrolumab (anti-IFNAR1) approved for SLE.
Entry Metadata
| Field | Value |
|---|---|
| ID | type-i-interferon |
| Name | Type I Interferon |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36-49. · PubMed 24362405
- Morand EF, Furie R, Tanaka Y, et al. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020;382(3):211-221. · PubMed 31851795
- Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574-1583. · PubMed 31745299